BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 16683135)

  • 1. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino.
    Karkare S; Bhatnagar D
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):575-86. PubMed ID: 16683135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptide nucleic acids, efficient tools for molecular diagnosis (Review).
    Pellestor F; Paulasova P
    Int J Mol Med; 2004 Apr; 13(4):521-5. PubMed ID: 15010851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chirality and optical purity in nucleic acid recognition by PNA and PNA analogs.
    Sforza S; Galaverna G; Dossena A; Corradini R; Marchelli R
    Chirality; 2002 Jul; 14(7):591-8. PubMed ID: 12112334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glowing locked nucleic acids: brightly fluorescent probes for detection of nucleic acids in cells.
    Østergaard ME; Cheguru P; Papasani MR; Hill RA; Hrdlicka PJ
    J Am Chem Soc; 2010 Oct; 132(40):14221-8. PubMed ID: 20845923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
    Hatamoto M; Ohashi A; Imachi H
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):397-402. PubMed ID: 20135118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
    Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
    Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide nucleic acids as therapeutic agents.
    Nielsen PE
    Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemical genosensor based on peptide nucleic acid-mediated PCR and asymmetric PCR techniques: Electrostatic interactions with a metal cation.
    Kerman K; Vestergaard M; Nagatani N; Takamura Y; Tamiya E
    Anal Chem; 2006 Apr; 78(7):2182-9. PubMed ID: 16579596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of PNA and LNA oligomers to chemotherapy.
    Elayadi AN; Corey DR
    Curr Opin Investig Drugs; 2001 Apr; 2(4):558-61. PubMed ID: 11566018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.
    Möhrle BP; Kumpf M; Gauglitz G
    Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
    Orum H; Wengel J
    Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics.
    Pellestor F; Paulasova P
    Eur J Hum Genet; 2004 Sep; 12(9):694-700. PubMed ID: 15213706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.
    Crinelli R; Bianchi M; Gentilini L; Palma L; Sørensen MD; Bryld T; Babu RB; Arar K; Wengel J; Magnani M
    Nucleic Acids Res; 2004; 32(6):1874-85. PubMed ID: 15051810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilabeled pyrene-functionalized 2'-amino-LNA probes for nucleic acid detection in homogeneous fluorescence assays.
    Hrdlicka PJ; Babu BR; Sørensen MD; Harrit N; Wengel J
    J Am Chem Soc; 2005 Sep; 127(38):13293-9. PubMed ID: 16173760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
    Kaihatsu K; Shah RH; Zhao X; Corey DR
    Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity and biotechnological aspects of peptide nucleic acid.
    Lundin KE; Good L; Strömberg R; Gräslund A; Smith CI
    Adv Genet; 2006; 56():1-51. PubMed ID: 16735154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA).
    Kaur H; Babu BR; Maiti S
    Chem Rev; 2007 Nov; 107(11):4672-97. PubMed ID: 17944519
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
    Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
    J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.